Biotech, CDMOs start to disclose tariff exposure with US trade inquiry underway news2025-04-16T12:43:58+00:00April 16th, 2025|Endpoints News|
J&J CEO chides Trump’s tariff plan to boost US drugmakingnews2025-04-15T18:53:47+00:00April 15th, 2025|Endpoints News|
Trump’s pharma probe sweeps in APIs, ‘key starting materials’news2025-04-15T16:54:42+00:00April 15th, 2025|Endpoints News|
Trump drug tariffs inch closer as Commerce Department launches 232 investigationnews2025-04-14T22:27:27+00:00April 14th, 2025|Endpoints News|
Pharma tariffs to arrive ‘in the next month or two,’ commerce secretary saysnews2025-04-14T11:00:54+00:00April 14th, 2025|Endpoints News|
CDMOs anticipate inspection bottlenecks after FDA firingsnews2025-04-11T13:18:17+00:00April 11th, 2025|Endpoints News|
Novartis follows Lilly and J&J in announcing multibillion-dollar US manufacturing investmentnews2025-04-10T19:40:42+00:00April 10th, 2025|Endpoints News|
Pharma tariffs: Here’s what a potential rollout could look likenews2025-04-10T15:20:15+00:00April 10th, 2025|Endpoints News|
DHL pours €2B into healthcare logistics; OXB revenues on the risenews2025-04-10T14:54:15+00:00April 10th, 2025|Endpoints News|
Novo Nordisk looks to Brazil to boost GLP-1 manufacturing with $1B+ budgetnews2025-04-09T10:49:20+00:00April 9th, 2025|Endpoints News|
